Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more
Baird Medical Investment Holdings Limited (BDMD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.090x
Based on the latest financial reports, Baird Medical Investment Holdings Limited (BDMD) has a cash flow conversion efficiency ratio of -0.090x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.19 Million) by net assets ($35.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Baird Medical Investment Holdings Limited - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Baird Medical Investment Holdings Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baird Medical Investment Holdings Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FAT Brands Inc
NASDAQ:FATBW
|
0.050x |
|
Hotel Fitra International Tbk PT
JK:FITT
|
-0.096x |
|
Higgstec
TWO:5220
|
0.008x |
|
IokCompany Co. Ltd
KQ:078860
|
-0.020x |
|
NSE S.A. EO 155
F:7YM
|
N/A |
|
Yuan Jen Enterprises Co Ltd
TW:1725
|
0.071x |
|
Australian Vintage Ltd
PINK:AUVGF
|
0.001x |
|
Scienture Holdings, Inc.
NASDAQ:SCNX
|
-0.039x |
Annual Cash Flow Conversion Efficiency for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual cash flow conversion efficiency of Baird Medical Investment Holdings Limited from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $39.76 Million | $-6.31 Million | -0.159x | -455.86% |
| 2023-12-31 | $35.71 Million | $-1.02 Million | -0.029x | -251.52% |
| 2022-12-31 | $25.78 Million | $485.97K | 0.019x | -94.31% |
| 2021-12-31 | $15.86 Million | $5.26 Million | 0.331x | -42.65% |
| 2020-12-31 | $6.76 Million | $3.91 Million | 0.578x | +395.65% |
| 2019-12-31 | $-22.58 Million | $4.41 Million | -0.195x | -- |